Types of insulin
NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin] injection)
One insulin, in one easy-to-use FlexPen®, that offers two different kinds of blood sugar control in one shot. NovoLog® Mix 70/30 is one way to simplify your insulin treatment plan.
NovoLog® Mix 70/30: Blood sugar control when you need it.
NovoLog® Mix 70/30 is a man-made insulin that is used to control high blood sugar in adults with diabetes mellitus. It’s one insulin that works in two different ways.
Some people take two different types of insulin to treat the ups and downs of blood sugar: One that can last for up to 24 hours, and one that treats the spikes in blood sugar levels that happen when you eat. But NovoLog® Mix 70/30 is one insulin that can cover both:
- Mealtime blood sugar levels
- In between meal times
Just watch the demo to see how simple using NovoLog® mix 70/30 FlexPen® can be.
What to know about risks and side effects.
First, make sure you read the important safety information below. It’s a good way to learn more about how to take NovoLog® Mix 70/30 and any possible side effects to watch out for.
Here are a few key things to keep in mind:
- You shouldn’t take NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in it
- You should eat within 15 minutes after using NovoLog® Mix 70/30 to avoid low blood sugar
- Always talk to your doctor before changing the type of insulin you use
- Never mix NovoLog® Mix 70/30 with other insulin products or use it in an insulin pump
- Make sure your doctor knows about any other medicines you’re taking and any other medical conditions you have
You may also want to read through some of these common questions and learn more about taking NovoLog® Mix 70/30 at NovoLogMix70-30.com.
Remember, NovoLog® Mix 70/30 may be a good option for you, but only your doctor can make that decision. So talk to your doctor about how NovoLog® Mix 70/30 might fit into your diabetes management plan, along with eating healthy and staying active.
Additional Important Safety Information
One study of people with type 2 diabetes found that NovoLog® Mix 70/30 did a better job of reducing blood glucose levels after meals than did human premix 70/30 insulin. A1C and fasting blood glucose levels were similar in both groups. The importance of differences in high postprandial (after-meal) glucose levels between the groups studied as it relates to long-term complications of diabetes has not been established.
Dosing of NovoLog® Mix 70/30 will differ among patients and should be set by the healthcare professional familiar with the patient's energy needs, eating habits, and other lifestyle factors. As with all insulins, the length of action may very according to the dose, injection site, blood flow, temperature, and level of physical activity and conditioning.
